# EDGAR Filing Document

**Accession Number:** 0001364954
**File Stem:** 0001364954-25-000096
**Filing Date:** 2025-8
**Character Count:** 135831
**Document Hash:** 5f3ed01ec23189dbce43f9e39f922bbc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001364954-25-000096.hdr.sgml**: 20250808

**ACCESSION NUMBER**: 0001364954-25-000096

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 81

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250808

**DATE AS OF CHANGE**: 20250808

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CHEGG, INC
- **CENTRAL INDEX KEY:** 0001364954
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-EDUCATIONAL SERVICES [8200]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 203237489
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36180
- **FILM NUMBER:** 251197879

**BUSINESS ADDRESS:**
- **STREET 1:** 3990 FREEDOM CIRCLE
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95054
- **BUSINESS PHONE:** 408-855-5700

**MAIL ADDRESS:**
- **STREET 1:** 3990 FREEDOM CIRCLE
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95054

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEGG INC
- **DATE OF NAME CHANGE:** 20060605

?xml version='1.0' encoding='ASCII'? chgg-20250630

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 30, 2025** 

**or**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from _________ to _________ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**

**Commission file number 001-36180** 

![Chegg new logo 2021.jpg](chgg-20250630_g1.jpg)

**CHEGG, INC.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Delaware** | **20-3237489** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |

---

**3990 Freedom Circle** 

**Santa Clara, CA, 95054** 

**(Address of principal executive offices)**

**(408) 855-5700** 

**(Registrant's telephone number, including area code)**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $0.001 par value per share | CHGG | The New York Stock Exchange |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (Exchange Act) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧No ◻

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧No ◻

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ⌧ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ | | |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ⌧

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• As of August 4, 2025, the Registrant had 108,326,990 outstanding shares of Common Stock.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

---

| | | |
|:---|:---|:---|
| | **TABLE OF CONTENTS** | |
| | | **<u>Page</u>** |
| | **<u>[PART I - FINANCIAL INFORMATION](#i97e364368d554c98b9ba52792f723c3b_13)</u>** | |
| <u>[Item 1.](#i97e364368d554c98b9ba52792f723c3b_16)</u> | <u>[Financial Statements (unaudited):](#i97e364368d554c98b9ba52792f723c3b_16)</u> | <u>[4](#i97e364368d554c98b9ba52792f723c3b_16)</u> |
|  | <u>[Condensed Consolidated Balance Sheets - June 30, 2025 and December 31, 2024](#i97e364368d554c98b9ba52792f723c3b_19)</u> | <u>[4](#i97e364368d554c98b9ba52792f723c3b_19)</u> |
|  | <u>[Condensed Consolidated Statements of Operations - for the Three](#i97e364368d554c98b9ba52792f723c3b_22)[and Six](#i97e364368d554c98b9ba52792f723c3b_22)[Months Ended](#i97e364368d554c98b9ba52792f723c3b_22)[June 3](#i97e364368d554c98b9ba52792f723c3b_22)[0](#i97e364368d554c98b9ba52792f723c3b_22)[, 2025 and 2024](#i97e364368d554c98b9ba52792f723c3b_22)</u> | <u>[5](#i97e364368d554c98b9ba52792f723c3b_22)</u> |
|  | <u>[Condensed Consolidated Statements of Comprehensive Loss - Three and Six Months Ended June 30, 2025 and 2024](#i97e364368d554c98b9ba52792f723c3b_25)</u> | <u>[6](#i97e364368d554c98b9ba52792f723c3b_25)</u> |
|  | <u>[Condensed Consolidated Statements of Stockholders' Equity - Three and Six Months Ended June 30, 2025 and 2024](#i97e364368d554c98b9ba52792f723c3b_28)</u> | <u>[7](#i97e364368d554c98b9ba52792f723c3b_28)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows - Three and Six Months Ended June 30, 2025 and 2024](#i97e364368d554c98b9ba52792f723c3b_31)</u> | <u>[9](#i97e364368d554c98b9ba52792f723c3b_31)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements](#i97e364368d554c98b9ba52792f723c3b_34)</u> | <u>[10](#i97e364368d554c98b9ba52792f723c3b_34)</u> |
| <u>[Item 2.](#i97e364368d554c98b9ba52792f723c3b_85)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i97e364368d554c98b9ba52792f723c3b_85)</u> | <u>[24](#i97e364368d554c98b9ba52792f723c3b_85)</u> |
| <u>[Item 3.](#i97e364368d554c98b9ba52792f723c3b_112)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i97e364368d554c98b9ba52792f723c3b_112)</u> | <u>[33](#i97e364368d554c98b9ba52792f723c3b_112)</u> |
| <u>[Item 4.](#i97e364368d554c98b9ba52792f723c3b_115)</u> | <u>[Controls and Procedures](#i97e364368d554c98b9ba52792f723c3b_115)</u> | <u>[33](#i97e364368d554c98b9ba52792f723c3b_115)</u> |
|  | **<u>[PART II - OTHER INFORMATION](#i97e364368d554c98b9ba52792f723c3b_118)</u>** |  |
| <u>[Item 1.](#i97e364368d554c98b9ba52792f723c3b_121)</u>  | <u>[Legal Proceedings](#i97e364368d554c98b9ba52792f723c3b_121)</u> | <u>[34](#i97e364368d554c98b9ba52792f723c3b_121)</u> |
| <u>[Item 1A.](#i97e364368d554c98b9ba52792f723c3b_124)</u>  | <u>[Risk Factors](#i97e364368d554c98b9ba52792f723c3b_124)</u> | <u>[34](#i97e364368d554c98b9ba52792f723c3b_124)</u> |
| <u>[Item 2.](#i97e364368d554c98b9ba52792f723c3b_127)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i97e364368d554c98b9ba52792f723c3b_127)</u> | <u>[34](#i97e364368d554c98b9ba52792f723c3b_127)</u> |
| <u>[Item 5.](#i97e364368d554c98b9ba52792f723c3b_130)</u> | <u>[Other Information](#i97e364368d554c98b9ba52792f723c3b_130)</u> | <u>[35](#i97e364368d554c98b9ba52792f723c3b_130)</u> |
| <u>[Item 6.](#i97e364368d554c98b9ba52792f723c3b_136)</u>  | <u>[Exhibits](#i97e364368d554c98b9ba52792f723c3b_136)</u> | <u>[36](#i97e364368d554c98b9ba52792f723c3b_136)</u> |
| <u>[Signatures](#i97e364368d554c98b9ba52792f723c3b_139)</u> | <u>[Signatures](#i97e364368d554c98b9ba52792f723c3b_139)</u> | <u>[37](#i97e364368d554c98b9ba52792f723c3b_139)</u> |

---

Unless the context requires otherwise, the words "we," "us," "our," "Company" and "Chegg" refer to Chegg, Inc. and its subsidiaries taken as a whole.

Chegg, Chegg.com, Chegg Study, EasyBib, the Chegg "C" logo, and Busuu are some of our trademarks used in this Quarterly Report on Form 10-Q. Solely for convenience, our trademarks, trade names and service marks referred to in this Quarterly Report on Form 10-Q appear without the®,™ and SM symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights to these trademarks and trade names. Other trademarks appearing in this Quarterly Report on Form 10-Q are the property of their respective holders.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**NOTE ABOUT FORWARD-LOOKING STATEMENTS** 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations and results of operations are forward-looking statements. The words "believe," "may," "will," "would," "could," "estimate," "continue," "anticipate," "intend," "project," "endeavor," "expect," "plan to," "if," "future," "likely," "potentially," and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described in Part I, Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as supplemented by the risks described under "Risk Factors" in Part II, Item 1A of this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should read this Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect.

Our forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q, and we undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**PART I - FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)**

**CHEGG, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(in thousands, except for number of shares and par value)**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **June 30,<br>2025** | **December 31,<br>2024** |
| **Assets** | | |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $36825 | $161475 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments | 48815 | 154249 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance of $125 and $190 at June 30, 2025 and December 31, 2024, respectively | 18055 | 23641 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 23683 | 17100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 76548 | 81094 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 203926 | 437559 |
| Long-term investments | 28474 | 212650 |
| Property and equipment, net | 135491 | 170648 |
| Intangible assets, net | 8194 | 10347 |
| Right of use assets | 19418 | 22256 |
| Other assets | 8950 | 15491 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $404453 | $868951 |
| **Liabilities and stockholders' equity** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $8321 | $15159 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 34759 | 39217 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 121373 | 115360 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of convertible senior notes, net | 62516 | 358605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 226969 | 528341 |
| Long-term liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Convertible senior notes, net |  | 127344 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term operating lease liabilities | 17700 | 18509 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other long-term liabilities | 1928 | 1776 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities | 19628 | 147629 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 246597 | 675970 |
| Commitments and contingencies (Note 8) |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $0.001 par value per share, 10,000,000 shares authorized, no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.001 par value per share: 400,000,000 shares authorized; 107,821,415 and 104,880,048 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 108 | 105 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 1133686 | 1114550 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (33350) | (32233) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (942588) | (889441) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 157856 | 192981 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $404453 | $868951 |

---

See Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**CHEGG, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(in thousands, except per share amounts)**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net revenues | $105120 | $163147 | $226507 | $337497 |
| &nbsp;&nbsp;Cost of revenues | 35478 | 45411 | 89451 | 91908 |
| Gross profit | 69642 | 117736 | 137056 | 245589 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;Research and development | 28717 | 43651 | 58145 | 88086 |
| &nbsp;&nbsp;Sales and marketing | 17417 | 23545 | 43031 | 53920 |
| &nbsp;&nbsp;General and administrative | 59966 | 54016 | 99340 | 109550 |
| &nbsp;&nbsp;Impairment expense |  | 481531 | 2000 | 481531 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 106100 | 602743 | 202516 | 733087 |
| Loss from operations | (36458) | (485007) | (65460) | (487498) |
| Interest expense, net and other income, net: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (41) | (651) | (508) | (1301) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | 2059 | 7119 | 15056 | 17899 |
| Total interest expense, net and other income, net | 2018 | 6468 | 14548 | 16598 |
| Loss before provision for income taxes | (34440) | (478539) | (50912) | (470900) |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | (1223) | (138345) | (2235) | (147404) |
| Net loss | $(35663) | $(616884) | $(53147) | $(618304) |
| Net loss per share, basic and diluted | $(0.33) | $(6.01) | $(0.50) | $(6.03) |
| Weighted average shares used to compute net loss per share, basic and diluted | 106908 | 102604 | 106039 | 102474 |

---

See Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**CHEGG, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS**

**(in thousands)**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net loss | $(35663) | $(616884) | $(53147) | $(618304) |
| Other comprehensive (loss) income |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in unrealized gains and losses on investments | (35) | (119) | (558) | (2089) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in foreign currency translation adjustments | (68) | 876 | (559) | (3087) |
| Other comprehensive (loss) income | (103) | 757 | (1117) | (5176) |
| Total comprehensive loss | $(35766) | $(616127) | $(54264) | $(623480) |

---

See Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**CHEGG, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

**(in thousands)**

**(unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** |
| | **Common Stock** | **Common Stock** | | | | |
| | **Shares** | **Par <br>Value** |<br>**Additional Paid-In<br>Capital** |<br>**Accumulated Other Comprehensive Loss** |<br>**Accumulated<br>Deficit** |<br>**Total Stockholders' Equity** |
| **Balances at March 31, 2025** | 105377 | $105 | $1125738 | $(33247) | $(906925) | $185671 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock upon issuance of ESPP | 558 | 1 | 388 |  |  | 389 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net share settlement of equity awards | 1886 | 2 | (568) |  |  | (566) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 8128 |  |  | 8128 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive loss |  |  |  | (103) |  | (103) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  | (35663) | (35663) |
| **Balances at June 30, 2025** | 107821 | $108 | $1133686 | $(33350) | $(942588) | $157856 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** |
| | **Common Stock** | **Common Stock** | | | | |
| | **Shares** | **Par <br>Value** |<br>**Additional Paid-In<br>Capital** |<br>**Accumulated Other Comprehensive Loss** |<br>**Accumulated<br>Deficit** |<br>**Total Stockholders' Equity** |
| **Balances at March 31, 2024** | 101570 | $102 | $1057837 | $(40672) | $(53793) | $963474 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock upon issuance of ESPP | 557 |  | 2188 |  |  | 2188 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net share settlement of equity awards | 1234 | 1 | (3531) |  |  | (3530) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 19495 |  |  | 19495 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  | 757 |  | 757 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  | (616884) | (616884) |
| **Balances at June 30, 2024** | 103361 | $103 | $1075989 | $(39915) | $(670677) | $365500 |

---

See Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** |
| | **Common Stock** | **Common Stock** | | | | |
| | **Shares** | **Par <br>Value** |<br>**Additional Paid-In<br>Capital** |<br>**Accumulated Other Comprehensive Loss** |<br>**Accumulated<br>Deficit** |<br>**Total Stockholders' Equity** |
| **Balances at December 31, 2024** | 104880 | $105 | $1114550 | $(32233) | $(889441) | $192981 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock upon issuance of ESPP | 558 | 1 | 388 |  |  | 389 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net share settlement of equity awards | 2383 | 2 | (1037) |  |  | (1035) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 19785 |  |  | 19785 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive loss |  |  |  | (1117) |  | (1117) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  | (53147) | (53147) |
| **Balances at June 30, 2025** | 107821 | $108 | $1133686 | $(33350) | $(942588) | $157856 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** |
| | **Common Stock** | **Common Stock** | | | | |
| | **Shares** | **Par <br>Value** |<br>**Additional Paid-In<br>Capital** |<br>**Accumulated Other Comprehensive Loss** |<br>**Accumulated<br>Deficit** |<br>**Total Stockholders' Equity** |
| **Balances at December 31, 2023** | 102824 | $103 | $1031627 | $(34739) | $(52373) | $944618 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock | (2116) | (2) | (112) |  |  | (114) |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock upon issuance of ESPP | 557 |  | 2188 |  |  | 2188 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net share settlement of equity awards | 2096 | 2 | (7825) |  |  | (7823) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense |  |  | 50111 |  |  | 50111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive loss |  |  |  | (5176) |  | (5176) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  | (618304) | (618304) |
| **Balances at June 30, 2024** | 103361 | $103 | $1075989 | $(39915) | $(670677) | $365500 |

---

See Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**CHEGG, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(in thousands)**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** |
| **Cash flows from operating activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(53147) | $(618304) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 19169 | 47336 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 48320 | 39393 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred tax assets | 149 | 141032 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease expense, net of accretion | 2019 | 3141 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 418 | 1081 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from write-offs of property and equipment | 558 | 1657 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on early extinguishment of debt | (7360) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Realized gain on sale of investments | (752) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment expense | 2000 | 481531 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of lease related assets | 3004 | 2189 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of strategic equity investment | 6000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss contingency | 7500 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-cash items | 325 | 82 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 6114 | 10561 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (941) | (12173) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 928 | (773) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (6038) | (12045) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | (5945) | (10226) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (1113) | (4057) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | (1522) | (2880) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 19686 | 67545 |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property and equipment | (15895) | (45817) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of investments | (793) | (123669) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Maturities of investments | 107710 | 89890 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of investments | 181158 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of strategic equity investment |  | 15500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) investing activities | 272180 | (64096) |
| **Cash flows from financing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of convertible senior notes&nbsp;&nbsp;&nbsp;&nbsp; | (416492) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of taxes related to the net share settlement of equity awards | (1037) | (7825) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from common stock issued under stock plans, net | 391 | 2190 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (417138) | (5635) |
| Effect of exchange rate changes | 491 | (305) |
| Net decrease in cash, cash equivalents and restricted cash | (124781) | (2491) |
| Cash, cash equivalents and restricted cash, beginning of period | 164359 | 137976 |
| Cash, cash equivalents and restricted cash, end of period | $39578 | $135485 |

---

---

| | | |
|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** |
| Supplemental cash flow data: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid during the period for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest | $224 | $224 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes, net of refunds | $1072 | $2729 |
| &nbsp;&nbsp;Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows from operating leases | $3775 | $4346 |
| &nbsp;&nbsp;Right of use assets obtained in exchange for lease obligations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating leases | $1636 | $663 |
| &nbsp;&nbsp;Non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued purchases of long-lived assets | $3050 | $5016 |

---

---

| | | |
|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** |
| Reconciliation of cash, cash equivalents and restricted cash: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $36825 | $133068 |
| Restricted cash included in other current assets | 1014 | 540 |
| Restricted cash included in other assets | 1739 | 1877 |
| Total cash, cash equivalents and restricted cash | $39578 | $135485 |

---

See Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**CHEGG, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**Note 1. Background and Basis of Presentation**

***Company and Background***

***Basis of Presentation***

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and applicable rules and regulations of the U.S. Securities and Exchange Commission ("SEC") regarding interim financial reporting. The condensed consolidated financial statements include the results of Chegg, Inc. and its wholly-owned subsidiaries. Significant intercompany balances and transactions have been eliminated. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, including normal recurring adjustments, necessary to present fairly our financial position as of June 30, 2025 and our results of operations, results of comprehensive loss, stockholders' equity and cash flows for the six months ended June 30, 2025 and 2024. Our results of operations, results of comprehensive loss, stockholders' equity, and cash flows for the six months ended June 30, 2025 are not necessarily indicative of the results to be expected for the full year.

We have a single operating and reportable segment and operating unit structure. The condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto that are included in our Annual Report on Form 10-K for the year ended December 31, 2024 (the Annual Report on Form 10-K) filed with the SEC.

Except for the following change to our policy on revenue recognition and deferred revenue, there have been no material changes to our significant accounting policies as compared to the significant accounting policies described in our Annual Report on Form 10-K. Our policy on revenue recognition and deferred revenue has been updated to address the revenue recognition of content licensing.

***Revenue Recognition and Deferred Revenue***

Revenues from content licensing are recognized upon fulfillment.

***Use of Estimates***

The preparation of financial statements in conformity with generally accepted accounting principles in the United States (U.S. GAAP) requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities; the disclosure of contingent liabilities at the date of the financial statements; and the reported amounts of revenues and expenses during the reporting periods. We base our estimates on historical experience, knowledge of current business conditions, and various other factors we believe to be reasonable under the circumstances. These estimates are based on management's knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ from these estimates, and such differences could be material to our financial position and results of operations. There have been no material changes in our use of estimates during the six months ended June 30, 2025 as compared to the use of estimates disclosed in Part II, Item 8 "Consolidated Financial Statements and Supplementary Data" contained in our Annual Report on Form 10-K for the year ended December 31, 2024.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

&nbsp;&nbsp;&nbsp;&nbsp;***Reclassification of Prior Period Presentation***

In order to conform with current period presentation, $1.0 million of deferred tax assets have been reclassified from deferred tax assets to other assets on our condensed consolidated balance sheet as of December 31, 2024. This change in presentation does not affect previously reported results.

***Goodwill Impairment***

Goodwill is tested for impairment at least annually or when certain events or indicators of impairment occur between annual impairment tests. During the three months ended June 30, 2024, in consideration of the sustained decline in our stock price, industry developments, and our financial performance, we evaluated our current operating performance. Accordingly, we determined that there were indicators of impairment and a quantitative assessment was necessary. In the quantitative assessment, we estimated the fair value of our reporting unit utilizing an income approach, based on the present value of future discounted cash flows, which is classified as Level 3 in the fair value hierarchy. Significant estimates used to determine fair value include the weighted average cost of capital, growth rates, and amount and timing of expected future cash flows. As a result of the quantitative assessment, we determined that goodwill was impaired as the fair value of our reporting unit was less than the carrying value. As such, during the three months ended June 30, 2024, we recorded a $439.7 million impairment expense equal to the excess of the carrying value of our reporting unit over the estimated fair value, which was classified as impairment expense on our condensed consolidated statements of operations.

***Leases***

During the three months ended June 30, 2025, we obtained $1.4 million of ROU assets in exchange for lease liabilities as we commenced a two year operating lease for an office space in the United Kingdom.

In connection with the May 2025 restructuring action, we announced the closure of our Portland office. As a result, during the three months ended June 30, 2025, we recorded a full impairment of $3.0 million, consisting of $2.4 million impairment of ROU assets and $0.6 million impairment of leasehold improvements, which was classified as a general and administrative expense on our consolidated statement of operations. Our intent and ability to sublease the office as well as the local market conditions were factored in when measuring the amount of impairment. For further information on the May 2025 restructuring action, see Note 12. Restructuring Charges".

***Recent Accounting Pronouncements***

*Recently Issued Accounting Pronouncements Not Yet Adopted*

In July 2025, the Financial Accounting Standards Board (FASB) issued *Accounting Standards Update (ASU) 2025-05, Financial Instruments—Credit Losses*. ASU 2025-05 introduces a practical expedient related to applying Accounting Standards Codification (ASC) 326-20 to current accounts receivable and contract assets. Early adoption is permitted, and the guidance will be applied on a prospective basis. The guidance is effective for annual periods beginning after December 15, 2025 and interim periods within those annual periods. We did not early adopt ASU 2025-05 and we are currently in the process of evaluating the impact of this guidance.

In November 2024, the FASB issued *ASU 2024-04, Debt—Debt with Conversion and Other Options*. ASU 2024-04 improves the relevance and consistency in application of the induced conversion guidance requirements in ASC 470-20—Debt. Early adoption is permitted, and the guidance can be applied on either a prospective or retrospective basis. The guidance is effective for annual periods beginning after December 15, 2025 and interim periods within those annual periods. We did not early adopt ASU 2024-04 and we are currently in the process of evaluating the impact of this guidance.

In November 2024, the Financial Accounting Standards Board (FASB) issued ASU 2024-03, *Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures*. ASU 2024-03 requires disclosure of specified information about certain costs and expenses in the notes to financial statements. Early adoption is permitted, and the guidance will be applied prospectively with the option to apply retrospectively. The guidance is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. We did not early adopt ASU 2024-03 and we are currently in the process of evaluating the impact of this guidance.

In March 2024, the FASB issued ASU 2024-02, *Codification Improvements—Amendments to Remove References to the Concepts Statements*. ASU 2024-02 removes various references to the FASB's Concepts Statements from the FASB's Accounting Standards Codification. Early adoption is permitted, and the guidance will be applied prospectively with the option

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

to apply retrospectively. The guidance is effective for annual periods beginning after December 15, 2024. We did not early adopt ASU 2024-02 and do not believe it will have a significant impact on our financial statements, however, we are currently in the process of evaluating the impact.

In December 2023, the FASB issued ASU 2023-09, *Improvements to Income Tax Disclosures*. ASU 2023-09 requires disaggregated information about our effective tax rate reconciliation as well as information on income taxes paid that meet a quantitative threshold. Early adoption is permitted, and the guidance will be applied prospectively with the option to apply retrospectively. The guidance is effective for annual periods beginning after December 15, 2024. We did not early adopt ASU 2023-09 and we are currently in the process of evaluating the impact of this guidance.

**Note 2. Revenues**

***Revenue Recognition***

Revenues are recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. The majority of our revenues are recognized over time as services are performed, with certain revenues being recognized at a point in time.

The following tables present our total net revenues for the periods shown disaggregated for our Subscription Services and Skills and Other product lines (in thousands, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Subscription Services | $89727 | $146813 | (39)% |
| Skills and Other | 15393 | 16334 | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net revenues | $105120 | $163147 | (36) |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Subscription Services | $197293 | $300864 | (34)% |
| Skills and Other | 29214 | 36633 | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net revenues | $226507 | $337497 | (33) |

---

During the three and six months ended June 30, 2025, we recognized revenues of $27.1 million and $34.2 million, respectively, that were included in our deferred revenue balance at the beginning of each respective reporting period. During the three and six months ended June 30, 2024, we recognized revenues of $38.9 million and $47.1 million, respectively, that were included in our deferred revenue balance at the beginning of each respective reporting period.

***Contract Balances***

The following table presents our accounts receivable, net, contract assets and deferred revenue balances (in thousands, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | | | **Change** |
| | **June 30,<br>2025** | **December 31, 2024** | $**%** |
| Accounts receivable, net | $18055 | $23641 | (24)% |
| Contract assets | 6428 | 7027 | (9) |
| Deferred revenue | 34759 | 39217 | (11) |

---

During the six months ended June 30, 2025, our accounts receivable, net balance decreased by $5.6 million, or 24%, primarily due to higher cash collections and seasonality of our business. During the six months ended June 30, 2025, our contract assets balance decreased by $0.6 million, or 9%, primarily due to cash collections from our Chegg Skills service. During the six months ended June 30, 2025, our deferred revenue balance decreased by $4.5 million, or 11%, primarily due to lower bookings and seasonality of our business.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Note 3. Net Loss Per Share**

The following table presents the computation of basic and diluted net loss per share (in thousands, except per share amounts):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| *Numerator:* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(35663) | $(616884) | $(53147) | $(618304) |
| *Denominator:* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average shares used to compute net loss per share, basic and diluted | 106908 | 102604 | 106039 | 102474 |
| Net loss per share, basic and diluted | $(0.33) | $(6.01) | $(0.50) | $(6.03) |

---

During the three and six months ended June 30, 2025 and 2024, basic and diluted net loss per share was the same, as the inclusion of all potential common shares outstanding would have been anti-dilutive.

The following table presents potential weighted-average shares of common stock outstanding that were excluded from the computation of diluted net loss per share because including them would have been anti-dilutive (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Shares related to stock plan activity | 9420 | 7421 | 9737 | 7286 |
| Shares related to convertible senior notes | 583 | 9234 | 3585 | 9234 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total common stock equivalents | 10003 | 16655 | 13322 | 16520 |

---

**Note 4. Cash and Cash Equivalents, Investments and Fair Value Measurements**

The following tables present our cash and cash equivalents, and investments' fair value level classification, adjusted cost, unrealized gain, unrealized loss and fair value as of June 30, 2025 and December 31, 2024 (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| | **Fair Value Level** | **Adjusted Cost** | **Unrealized Gain** | **Unrealized Loss** | **Fair Value** |
| Cash and cash equivalents: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash |  | $25977 | $— | $— | $25977 |
| &nbsp;&nbsp;&nbsp;&nbsp;Money market funds | Level 1 | 10848 | $— | $— | $10848 |
| Total cash and cash equivalents |  | $36825 | $— | $— | $36825 |
| Short-term investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate debt securities | Level 2 | $48691 | $129 | $(5) | $48815 |
| Long-term investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate debt securities | Level 2 | $28308 | $166 | $— | $28474 |

---

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Fair Value Level** | **Adjusted Cost** | **Unrealized Gain** | **Unrealized Loss** | **Fair Value** |
| Cash and cash equivalents: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash |  | $28716 | $— | $— | $28716 |
| &nbsp;&nbsp;&nbsp;&nbsp;Money market funds | Level 1 | 132759 |  |  | 132759 |
| Total cash and cash equivalents |  | $161475 | $— | $— | $161475 |
| Short-term investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate debt securities | Level 2 | $113968 | $157 | $(29) | $114096 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. treasury securities | Level 1 | 40162 |  | (9) | 40153 |
| Total short-term investments |  | $154130 | $157 | $(38) | $154249 |
| Long-term investments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate debt securities | Level 2 | $133516 | $736 | $(78) | $134174 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. treasury securities | Level 1 | 78405 | 97 | (26) | 78476 |
| Total long-term investments |  | $211921 | $833 | $(104) | $212650 |

---

As of June 30, 2025, we determined that the unrealized losses on our investments were not driven by credit related factors. During the three and six months ended June 30, 2025 and 2024, we did not recognize any losses on our investments due to credit related factors and our realized gains and losses on investments were not significant.

The following table presents our cash equivalents and investments' adjusted cost and fair value by contractual maturity as of June 30, 2025 (in thousands):

---

| | | |
|:---|:---|:---|
| | **Adjusted Cost** | **Fair Value** |
| Due within one year | $48691 | $48815 |
| Due after one year through three years | 28308 | 28474 |
| Investments not due at a single maturity date | 10848 | 10848 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $87847 | $88137 |

---

Investments not due at a single maturity date in the preceding table consisted of money market funds.

***Strategic Investments***

In July 2022, we completed an investment of $6.0 million in Knack Technologies, Inc. (Knack), a privately held U.S. based peer-to-peer tutoring platform for higher education institutions. We do not have the ability to exercise significant influence over Knack's operating and financial policies and have elected to account for our investment at cost as it does not have a readily determinable fair value. During the three months ended June 30, 2025, we recorded a $6.0 million impairment charge on our investment in Knack included within general and administrative expense on our condensed consolidated statements of operations. Our impairment assessment was the result of changes in our rights as an investor and uncertainty around Knack's ability to support their future operations.

***Financial Instruments Not Recorded at Fair Value on a Recurring Basis***

We report our financial instruments at fair value with the exception of the 2026 notes. The estimated fair value of the 2026 notes was determined based on the trading price as of the last day of trading for the period. We consider the fair value of the 2026 notes to be a Level 2 measurement due to the limited trading activity. The estimated fair value of the 2026 notes as of June 30, 2025 and December 31, 2024 was $49.5 million and $105.8 million, respectively. For further information on the 2026 notes, refer to Note 7, "Convertible Senior Notes."

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Note 5. Property and Equipment, Net**

Property and equipment, net consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| Content | $344533 | $381629 |
| Software | 44109 | 67612 |
| Leasehold improvements | 7926 | 8207 |
| Furniture and fixtures | 2459 | 3346 |
| Computer and equipment | 2501 | 2953 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and equipment | 401528 | 463747 |
| Less accumulated depreciation | (266037) | (293099) |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | $135491 | $170648 |

---

Depreciation expense during the three and six months ended June 30, 2025 was $15.2 million and $46.2 million, respectively. Depreciation expense during the three and six months ended June 30, 2024 was $16.2 million and $31.9 million, respectively.

During the six months ended June 30, 2025, we streamlined our product experiences. As a result, we elected to abandon certain content and internal-use software assets and recorded charges of $18.2 million, consisting of $16.2 million of accelerated depreciation classified as cost of revenues on our condensed consolidated statements of operations and $2.0 million of impairment of in-progress internal-use software assets classified as impairment expense on our condensed consolidated statements of operations.

**Note 6. Balance Sheet Details**

***Other Current Assets***

Other current assets consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| Insurance loss recovery | $55000 | $55000 |
| Restricted cash | 1014 | 956 |
| Other | 20534 | 25138 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | $76548 | $81094 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

***Accrued Liabilities***

Accrued liabilities consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| Loss contingency | $69500 | $62000 |
| Taxes payable | 11712 | 11319 |
| Current operating lease liabilities | 4622 | 5625 |
| Restructuring liability | 8479 | 7310 |
| Other | 27060 | 29106 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | $121373 | $115360 |

---

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Note 7. Convertible Senior Notes**

In March/April 2019, we issued $800 million in aggregate principal amount of 0.125% convertible senior notes due in 2025 (2025 notes). The 2025 notes matured on March 15, 2025 and we paid $358.9 million to repay them which was classified as a financing activity on our condensed consolidated statements of cash flows.

In August 2020, we issued $1.0 billion in aggregate principal amount of 0% convertible senior notes due in 2026 (2026 notes, together with the 2025 notes, the notes). The 2026 notes bear no interest and will mature on September 1, 2026, unless repurchased, redeemed or converted in accordance with their terms prior to such date.

Each $1,000 principal amount of the 2026 notes will initially be convertible into 9.2978 shares of our common stock. This is equivalent to an initial conversion price of approximately $107.55 per share, which is subject to adjustment in certain circumstances. Prior to the close of business on the business day immediately preceding June 1, 2026 for the 2026 notes, the notes are convertible at the option of holders only upon satisfaction of certain circumstances. During the three months ended June 30, 2025, the circumstances allowing holders of the 2026 notes to convert were not met. On or after June 1, 2026 for the 2026 notes until the close of business on the second scheduled trading day immediately preceding the respective maturity dates, holders may convert their notes at any time, regardless of the circumstances. As of June 30, 2025, the 2026 notes were classified as a current liability on our condensed consolidated balance sheets as they will be convertible at the option of the holders on or after June 1, 2026.

In March 2025, in connection with our securities repurchase program, we extinguished $65.2 million aggregate principal amount of the 2026 notes in privately-negotiated transactions for a total consideration of $57.4 million, which was paid to the holders in cash. We also incurred approximately $0.2 million in fees resulting in a total reacquisition price of $57.6 million. The carrying amount of the extinguished notes was $64.9 million resulting in a $7.4 million gain on early extinguishment of debt. We elected to reacquire and not cancel the extinguished 2026 notes and left the associated capped call transactions outstanding.

The following table presents the net carrying amount of the notes (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **2026 Notes** | **2025 Notes** | **2026 Notes** | **2025 Notes** |
| Principal | $62710 | $— | $127906 | $358914 |
| Unamortized issuance costs | (194) |  | (562) | (309) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net carrying amount | $62516 | $— | $127344 | $358605 |

---

The following table presents the total interest expense recognized related to the notes (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **2026 notes:** |  |  |  |  |
| Contractual interest expense | $— | $— | $— | $— |
| Amortization of issuance costs | 41 | 160 | 110 | 321 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total 2026 notes interest expense | $41 | $160 | $110 | $321 |
| **2025 notes:** |  |  |  |  |
| Contractual interest expense | $— | $111 | $90 | $220 |
| Amortization of issuance costs |  | 380 | 308 | 760 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total 2025 notes interest expense | $— | $491 | $398 | $980 |

---

***Capped Call Transactions***

Concurrently with the offering of the 2026 notes, we used $103.4 million of the net proceeds to enter into privately negotiated capped call transactions which are expected to reduce or offset potential dilution to holders of our common stock upon conversion of the notes or offset the potential cash payments we would be required to make in excess of the principal amount of any converted notes. The capped call transactions automatically exercise upon conversion of the notes and as of June 30, 2025, cover 9,297,800 shares of our common stock for the 2026 notes. These are intended to effectively increase the overall conversion price from $107.55 to $156.44 per share for the 2026 notes. The effective increase in conversion price as a

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

result of the capped call transactions serves to reduce potential dilution to holders of our common stock and/or offset the cash payments we are required to make in excess of the principal amount of any converted notes. As these transactions meet certain accounting criteria, they are recorded in stockholders' equity as a reduction of additional paid-in capital on our condensed consolidated balance sheets and are not accounted for as derivatives. The fair value of the capped call instrument is not remeasured each reporting period. The cost of the capped call is not expected to be deductible for tax purposes.

**Note 8. Commitments and Contingencies**

We may from time to time be subject to certain legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, patents, copyrights, and other intellectual property rights; employment claims; and general contract or other claims. We may also, from time to time, be subject to various legal or government claims, demands, disputes, investigations, or requests for information. Such matters may include, but not be limited to, claims, disputes, or investigations related to warranty, refund, breach of contract, employment, intellectual property, government regulation, or compliance or other matters.

On June 27, 2025, Alicia Freeman, individually and on behalf of all others similarly situated, filed a complaint in California Superior Court, Santa Clara County asserting violations of certain California privacy laws and seeking declaratory relief and compensatory, punitive, and statutory damages, and attorneys' fees. Currently, losses are reasonably possible, but not estimable. The Company disputes these claims and intends to vigorously defend itself in this matter.

On March 1, 2023, Plaintiff Shiva Stein, derivatively on behalf of Chegg, filed a stockholder derivative complaint in the Court of Chancery of the State of Delaware (Case No. 2023-0244-NAC) asserting breach of fiduciary duty, unjust enrichment, and waste of corporate asset claims against members of Chegg's Board and certain Chegg officers. The matter is stayed. The Company disputes these claims and intends to vigorously defend itself in this matter.

On December 22, 2022, JPMorgan Chase Bank, N.A. (JPMC) asserted a demand for repayment by the Company of certain investment proceeds received by the Company in its capacity as an investor in TAPD, Inc. (more commonly known as "Frank"). JPMC seeks such repayment pursuant to certain provisions in the existing Support Agreement between JPMC and the Company that was entered into in connection with JPMC's acquisition of Frank. JPMC has alleged fraud on the part of certain former Frank executives regarding the quantity and quality of its customer accounts. The Company is not at fault, however, is pursuing resolution with JPMC.

On March 30, 2022, Joseph Robinson, derivatively on behalf of Chegg, filed a shareholder derivative complaint against Chegg and certain of its current and former directors and officers in the United States District Court for the Northern District of California, alleging violations of securities laws and breaches of fiduciary duties. On February 22, 2023, Plaintiff filed an Amended Shareholder Derivative Complaint. This matter has been consolidated with Choi, below, and both matters are stayed. The Company disputes these claims and intends to vigorously defend itself in this matter.

On January 12, 2022, Rak Joon Choi, derivatively on behalf of Chegg, filed a shareholder derivative complaint against Chegg and certain of its current and former directors and officers in the United States District Court for the Northern District of California, alleging violations of securities laws, breaches of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets. On February 22, 2023, Plaintiff filed an Amended Shareholder Derivative Complaint. This matter has been consolidated with Robinson, above, and both matters are stayed. The Company disputes these claims and intends to vigorously defend itself in this matter.

On December 22, 2021, Steven Leventhal, individually and on behalf of all others similarly situated, filed a purported securities fraud class action on behalf of all purchasers of Chegg common stock between May 5, 2020 and November 1, 2021, inclusive, against Chegg and certain of its current and former officers in the United States District Court for the Northern District of California (Case No. 5:21-cv-09953), alleging that Chegg and several of its officers made materially false and misleading statements in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 as amended (the Exchange Act). On September 7, 2022, KBC Asset Management and The Pompano Beach Police & Firefighters Retirement System were appointed as lead plaintiff in the case. On December 8, 2022, Plaintiff filed his Amended Complaint seeking unspecified compensatory damages, costs, and expenses, including counsel and expert fees. On September 26, 2024, the parties participated in an in-person mediation and reached a settlement in principle to pay $55.0 million wherein the Company denies any and all allegations of fault, liability, wrongdoing, or damages. On November 6, 2024, Plaintiffs filed a motion for preliminary approval of the settlement. The Court held a final approval hearing on April 24, 2025 and issued its final order approving of the settlement on May 21, 2025. The estimated contingent liability for the loss contingency recorded was $55.0 million as of June 30, 2025 and was included within accrued liabilities on our condensed consolidated balance sheets.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

The same amount was recorded for expected insurance loss recoveries, which is included within other current assets on our condensed consolidated balance sheets.

On September 13, 2021, Pearson Education, Inc. (Pearson) filed a complaint captioned Pearson Education, Inc. v. Chegg, Inc. (Pearson Complaint) in the United States District Court for the District of New Jersey against the Company (Case 2:21-cv-16866), alleging infringement of Pearson's registered copyrights and exclusive rights under copyright in violation of the United States Copyright Act. Pearson is seeking injunctive relief, monetary damages, costs, and attorneys' fees. The Company filed its answer to the Pearson Complaint on November 19, 2021. Pearson's June 29, 2022 Motion for Leave to File Amended Complaint seeking to add Bedford, Freeman & Worth Publishing Group, LLC d/b/a Macmillan Learning as a plaintiff was denied. Pearson filed an Amended Complaint on May 10, 2023, and the Company filed an amended answer on June 7, 2023. Chegg and Pearson have resolved this litigation. Pursuant to the terms of the parties' confidential settlement, the Court dismissed the case with prejudice on December 20, 2024. While the terms of the settlement are confidential, Chegg's decision to settle the lawsuit was driven by the expense, burden and uncertainty of ongoing protracted litigation.

On June 18, 2020, we received a Civil Investigative Demand (CID) from the Federal Trade Commission (FTC) regarding certain alleged deceptive or unfair acts or practices related to consumer privacy and/or data security. On October 31, 2022, the FTC published the parties' agreed-upon consent order regarding Chegg's privacy and data security practices. On January 27, 2023, the FTC finalized its order (Final Order) requiring Chegg to implement a comprehensive information security program, limit the data the Company can collect and retain, offer users multi factor authentication to secure their accounts, and allow users to request access to and delete their data. We have cooperated with the FTC on their investigation into our implementation of the final order and expect to resolve the matter to the parties' satisfaction and without any requirements or payments.

We have also been cooperating with the FTC with respect to another CID (the "ROSCA CID") relating to our compliance with the Federal Trade Commission Act and the Restore Online Shoppers' Confidence Act. The investigation concerns certain of our practices related to online transactions and consumer cancellation options. We have entered into a settlement agreement with the FTC in connection with the ROSCA CID, which remains subject to both FTC and court approval, containing injunctive provisions and a monetary component of $7.5 million. During the three months ended June 30, 2025, we recorded a $7.5 million contingent liability included within accrued liabilities on our condensed consolidated balance sheets and as a general and administrative expense on our condensed consolidated statements of operations.

We record a contingent liability for loss contingencies related to legal matters when a loss is both probable and reasonably estimable. Additionally, we record an insurance loss recovery up to the recognized loss contingency when realization is probable. Related to the above matters, as of June 30, 2025, the net impact of contingent liabilities less the related insurance loss recovery is $14.5 million. For those matters upon which we have sufficient insurance coverage, we have recorded contingent liabilities within accrued liabilities and the loss recovery from insurance within other current assets on our condensed consolidated balance sheets. We are not aware of any other pending legal matters or claims, individually or in the aggregate, which are expected to have a material adverse impact on our consolidated financial position, results of operations, or cash flows. Our analysis of whether a claim will proceed to litigation cannot be predicted with certainty, nor can the results of litigation be predicted with certainty. Nevertheless, defending any of these actions, regardless of the outcome, may be costly, time consuming, distract management personnel and have a negative effect on our business. In the ordinary course of business and for certain of the above matters, we are actively pursuing all avenues and strategies to resolve these matters, including available legal remedies, remediation and settlement negotiations with the parties. An adverse outcome in any of these actions, including a judgment or settlement, may cause a material adverse effect on our future business, operating results or financial condition.

**Note 9. Guarantees and Indemnifications**

We have agreed to indemnify our directors and officers for certain events or occurrences, subject to certain limits, while such persons are or were serving at our request in such capacity. We may terminate the indemnification agreements with these persons upon termination of employment, but termination will not affect claims for indemnification related to events occurring prior to the effective date of termination. We have a directors' and officers' insurance policy that covers our potential exposure up to the limits of our insurance coverage. In addition, we also have other indemnification agreements with various vendors against certain claims, liabilities, losses, and damages. The maximum amount of potential future indemnification is unlimited.

We believe the fair value of these indemnification agreements is immaterial. We have not recorded any liabilities for these agreements as of June 30, 2025.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Note 10. Common Stock**

We are authorized to issue 400 million shares of our common stock, with a par value per share of $0.001. As of June 30, 2025, we have reserved the following shares of our common stock for future issuance:

---

| | |
|:---|:---|
| | **June 30, 2025** |
| Shares available for grant under the 2023 Equity Incentive Plan | 11141440 |
| Outstanding RSUs and PSUs | 8664787 |
| Shares available for issuance under the Amended and Restated 2013 Employee Stock Purchase Plan | 2448986 |
| Shares available for grant under the 2023 Equity Inducement Plan | 1466489 |
| Outstanding stock options | 159795 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total common shares reserved for future issuance | 23881497 |

---

***Stock Plans***

*Amended 2023 Equity Incentive Plan*

On April 7, 2023, our Board of Directors adopted our 2023 Equity Incentive Plan (the "2023 EIP"), which was subsequently approved by our stockholders and became effective on June 7, 2023, replacing our 2013 Equity Incentive Plan (the "2013 Plan"). On the effective date of the 2023 EIP, 12,000,000 shares of our common stock were reserved for issuance. On June 6, 2023, the date on which the 2013 Plan expired, all remaining shares available for grant under the 2013 Plan were cancelled, and we will not make any additional grants under the 2013 Plan. In addition, any shares subject to awards, including shares subject to awards granted under the 2013 Plan that were outstanding on June 7, 2023, that are cancelled, forfeited, repurchased, expire by their terms without shares being issued, are used to pay the exercise price of an option or stock appreciation right or withheld to satisfy the tax withholding obligations related to any award, will be returned to the pool of shares available for grant and issuance under the 2023 EIP. On April 17, 2025, our Board of Directors adopted an amendment to the 2023 EIP, which was subsequently approved by our stockholders and became effective on June 4, 2025. The amendment to the 2023 EIP increases our common stock reserved for issuance under the Plan by 5,000,000 shares. The 2023 EIP permits the granting of incentive stock options, non-qualified stock options, RSUs, restricted stock awards, stock bonus awards, stock appreciation rights and performance awards. The 2023 EIP terminates on April 7, 2033. As of June 30, 2025, there were 11,141,440 shares available for grant under the 2023 EIP.

*Amended and Restated 2013 Employee Stock Purchase Plan*

On April 7, 2023, our Board of Directors adopted our Amended and Restated 2013 Employee Stock Purchase Plan (the "A&R ESPP"), which was subsequently approved by our stockholders and became effective on June 7, 2023. The A&R ESPP permits eligible employees to purchase shares of our common stock by accumulating funds through periodic payroll deductions. The A&R ESPP is intended to qualify as an "employee stock purchase plan" under Section 423 of the Code. Under the A&R ESPP, eligible employees will be granted an option to purchase shares of our common stock at a 15% discount to the lesser of the fair market value of our common stock on (i) the first trading day of the applicable offering period or (ii) the last day of each purchase period in the applicable offering period. The Compensation Committee of our Board of Directors shall determine the duration and commencement date of each offering period, provided that an offering period shall in no event be longer than twenty-seven (27) months, except as otherwise provided by an applicable sub-plan. Upon approval of the A&R ESPP, the available share pool under our existing 2013 Employee Stock Purchase Plan was reduced, and we have reserved 4,000,000 shares of our common stock under the A&R ESPP. As of June 30, 2025, there were 2,448,986 shares of common stock available for future issuance under the A&R ESPP.

*2023 Equity Inducement Plan*

On October 11, 2023, our Board of Directors approved and adopted our 2023 Equity Inducement Plan (the "2023 EINP"). On the effective date of the 2023 EINP, 2,000,000 shares of our common stock were reserved for issuance and as of June 30, 2025, there were 1,466,489 shares of common stock available for future issuance. The 2023 EINP permits the granting of non-qualified stock options and restricted stock unit awards. The 2023 EINP terminates on the later of (i) October 11, 2033 or (ii) ten years from the last date that additional shares are added to the EINP by the Compensation Committee of our Board of Directors.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Note 11. Stockholders' Equity**

***Share Repurchases***

During the six months ended June 30, 2025, we had no cash repurchases of our common stock.

During the year ended December 31, 2024, we repurchased 2,115,952 shares of our common stock related to the final delivery of our November 2023 accelerated share repurchase (ASR) agreement. The November 2023 ASR settled, and we were not required to make any additional cash payments or delivery of common stock to the financial institution upon settlement.

***Securities Repurchase Program***

In November 2024, our board of directors approved a $300.0 million increase to our existing securities repurchase program authorizing the repurchase of our common stock and/or convertible notes, through open market purchases, block trades, and/or privately negotiated transactions or pursuant to Rule 10b5-1 plans, in compliance with applicable securities laws and other legal requirements. The timing, volume, and nature of the repurchases will be determined by management based on the capital needs of the business, market conditions, applicable legal requirements, alternative investment opportunities, and other factors. As of June 30, 2025, we had $150.1 million remaining under the securities repurchase program, which has no expiration date and will continue until otherwise suspended, terminated or modified at any time for any reason by our board of directors.

***Share-based Compensation Expense***

The following table presents total share-based compensation expense recorded (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Cost of revenues | $131 | $466 | $369 | $979 |
| Research and development | 1584 | 7123 | 4796 | 16332 |
| Sales and marketing | 413 | 1726 | 1474 | 3866 |
| General and administrative | 5784 | 8732 | 12530 | 26159 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total share-based compensation expense | $7912 | $18047 | $19169 | $47336 |

---

During the three and six months ended June 30, 2025, we capitalized share-based compensation expense of $0.2 million and $0.6 million, respectively. During the three and six months ended June 30, 2024, we capitalized share-based compensation expense of $1.4 million and $2.7 million, respectively. As of June 30, 2025, total unrecognized share-based compensation expense was approximately $23.7 million, which is expected to be recognized over the remaining weighted-average vesting period of approximately 1.4 years.

The following table presents activity for outstanding RSUs and PSUs:

---

| | | |
|:---|:---|:---|
| | **RSUs and PSUs Outstanding** | **RSUs and PSUs Outstanding** |
| | **Shares Outstanding** | **Weighted Average Grant Date Fair Value** |
| Balance at December 31, 2024 | 7386965 | $10.58 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 6375000 | 1.49 |
| &nbsp;&nbsp;&nbsp;&nbsp;Released | (3607602) | 7.70 |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | (1489576) | 18.44 |
| Balance at June 30, 2025 | 8664787 | $3.69 |

---

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Note 12. Restructuring Charges**

***May 2025 Restructuring Plan***

In May 2025, we announced a workforce reduction that resulted in a management approved restructuring plan. As of June 30, 2025, we recorded $19.1 million of cumulative restructuring charges, primarily related to one-time employee termination benefits, which were classified primarily within operating expenses on our condensed consolidated statement of operations based on employees' job function. The restructuring liability is included within accrued liabilities on our condensed consolidated balance sheets. We estimate we will incur between $11 million and $13 million of additional restructuring charges over the next two fiscal quarters and we expect the plan to be substantially completed by the first quarter of the fiscal year 2026.

The following table presents a reconciliation of the beginning and ending restructuring liability balance (in thousands):

---

| | |
|:---|:---|
| | **Six Months Ended<br>June 30, 2025** |
| Beginning balance | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | 19056 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring payments | (10809) |
| Ending balance | $8247 |

---

***November 2024 Restructuring Plan***

In November 2024, we announced a workforce reduction that resulted in a management approved restructuring plan. As of June 30, 2025, we recorded $17.1 million of cumulative restructuring charges, primarily related to one-time employee termination benefits, which were classified primarily within operating expenses on our condensed consolidated statement of operations based on employees' job function. The restructuring liability is included within accrued liabilities on our condensed consolidated balance sheets. The total amount of restructuring charges has been recorded and we expect the plan to be substantially completed by the end of the third quarter of fiscal 2025.

The following table presents a reconciliation of the beginning and ending restructuring liability balance (in thousands):

---

| | |
|:---|:---|
| | **Six Months Ended<br>June 30, 2025** |
| Beginning balance | $3915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | 2458 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring payments | (6141) |
| Ending balance | $232 |

---

***June 2024 Restructuring Plan***

In June 2024, we announced a workforce reduction that resulted in a management approved restructuring plan. As of June 30, 2025, we recorded $10.3 million of cumulative restructuring charges. During the three and six months ended June 30, 2024, we recorded $6.7 million of restructuring charges. Restructuring charges are primarily related to one-time employee termination benefits, which were classified primarily within operating expenses on our condensed consolidated statement of operations based on employees' job function. The restructuring liability is included within accrued liabilities on our condensed consolidated balance sheets. The total amount of restructuring charges has been recorded and the plan is completed.

The following table presents a reconciliation of the beginning and ending restructuring liability balance (in thousands):

---

| | |
|:---|:---|
| | **Six Months Ended<br>June 30, 2025** |
| Beginning balance | $3395 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | 328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring payments | (3723) |
| Ending balance | $— |

---

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Note 13. Segment Information**

Our chief operating decision maker is our Chief Executive Officer who makes resource allocation decisions and reviews financial information presented on a consolidated basis. Accordingly, we have determined that we have a single operating and reportable segment and operating unit structure.

Our chief operating decision maker uses net loss in assessing performance and determining how to allocate resources and is regularly provided with cost of revenues, paid marketing expenses, and consolidated operating expenses when reviewing financial information as part of the annual budgeting and forecasting process as well as the review over quarterly budget to actual variances.

The following table presents information about our significant segment expenses and includes a reconciliation to net loss (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net revenues | $105120 | $163147 | $226507 | $337497 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;Cost of revenues | 35478 | 45411 | 89451 | 91908 |
| &nbsp;&nbsp;Research and development | 28717 | 43651 | 58145 | 88086 |
| &nbsp;&nbsp;Paid marketing expenses<sup>(1)</sup> | 7054 | 8116 | 23433 | 24451 |
| &nbsp;&nbsp;Other sales and marketing<sup>(2)</sup> | 10363 | 15429 | 19598 | 29469 |
| &nbsp;&nbsp;General and administrative | 59966 | 54016 | 99340 | 109550 |
| &nbsp;&nbsp;Impairment expense |  | 481531 | 2000 | 481531 |
| Total segment expenses | 141578 | 648154 | 291967 | 824995 |
| &nbsp;&nbsp;Other segment items<sup>(3)</sup> | 795 | (131877) | 12313 | (130806) |
| Net loss | $(35663) | $(616884) | $(53147) | $(618304) |

---

_____________________________________________________

<sup>(1)</sup> Paid marketing expenses consist primarily of online advertising and marketing promotional expenditures.

<sup>(2)</sup> Other sales and marketing primarily consists of employee related expenses, including share-based compensation expense, and depreciation and amortization expenses.

<sup>(3)</sup> Other segment items consist of interest expense, other income, and provision for income taxes.

We derive our revenues from our Subscription Services and Skills and Other product lines. Our Subscription Services include Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu. Our Skills and Other product line includes revenues from Chegg Skills, advertising services, content licensing, print textbooks and eTextbooks.

The following table presents our total net revenues for our Subscription Services and Skills and Other product lines (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Subscription Services | $89727 | $146813 | $197293 | $300864 |
| Skills and Other | 15393 | 16334 | 29214 | 36633 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net revenues | $105120 | $163147 | $226507 | $337497 |

---

The following table presents our total net revenues by geographic area (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| United States | $90145 | $141653 | $195642 | $293785 |
| International | 14975 | 21494 | 30865 | 43712 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net revenues | $105120 | $163147 | $226507 | $337497 |

---

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

The following table presents our long-lived assets by geographic area (in thousands):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| United States | $132311 | $172483 |
| International | 22598 | 20421 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total long-lived assets | $154909 | $192904 |

---

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*You should read the following discussion of our financial condition and results of operations in conjunction with our condensed consolidated financial statements and the related notes included in Part I, Item 1, "Financial Statements (unaudited)" of this Quarterly Report on Form 10-Q. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. See the section titled "Note about Forward-Looking Statements" for additional information. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Quarterly Report on Form 10-Q.*

**Overview**

Our long-term strategy is centered upon our ability to utilize our Subscription Services to increase student engagement with our learning platform. We continue to invest in the expansion of our offerings and technology platform to provide a more compelling and personalized solution and deepen engagement with students. We continue to integrate artificial intelligence into our platform, and it is now conversational, more instructional, and interactive. We remain focused on providing a holistic and differentiated product offering that supports the whole student with 360 degrees of individualized academic and functional support, including the delivery of high-quality and accurate content. We believe the investments we are making will allow us to return to revenue growth over time. Our ability to achieve these long-term objectives is subject to numerous risks and uncertainties, which are described in greater detail below and in Part II, Item 1A, "Risk Factors."

***Exploration of Strategic Alternatives***

On February 24, 2025, we announced that we are undertaking a strategic review process and exploring a range of alternatives to maximize shareholder value, including being acquired, undertaking a go-private transaction, or remaining as a standalone public company. This review is ongoing with our continued investment, innovation, and execution. We have not set a timetable for the completion of this process, and there can be no assurance that it will result in any transaction or outcome.

***Business Updates and Developments***

Recent technological shifts, notably Google's roll out of its AI Overviews search experience, or AIO, and continued increase in adoption of free and paid generative AI services by students, have created and are expected to continue to create headwinds for our industry and our business, most notably a reduction in traffic to our website and customers subscribing to our services. In August 2024, Google broadly rolled out AIO, which displays AI-generated content at the top of its search results. This experience, which includes questions and solutions for education, keeps users on Google search results versus leading them onto our site. AIO's prevalence has grown and will only continue to increase. While we continue to study the changes and adjust our SEO strategy, we expect Google to continue its shift from being a search origination point to the destination, which could materially adversely affect our business, operating results and financial condition.

In addition, across our industry, there has been a continued increase in the adoption of free and paid generative AI products for academic support, and students are increasingly turning to generative AI for academic support, such as homework and exams, as well as assistance in other areas of daily life. This issue impacts education technology companies broadly, where students see generative AI products like Chat GPT and others as strong alternatives to vertically specialized solutions for education such as Chegg. These developments have negatively impacted our industry and our business and are expected to continue to impact our overall traffic and accelerate the decline in the number of new subscribers that sign up for our services, resulting in continued negative impacts to our growth, business, operating results and financial condition. See Part II, Item 1A, "Risk Factors" for additional details.

In May 2025, we announced an additional restructuring plan to further manage costs and align with the market. The May 2025 restructuring plan included a reduction in workforce and the closure of one office. We estimate we will incur between $11 million and $13 million of additional restructuring charges over the next two fiscal quarters and we expect the plan to be

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

substantially completed by the first quarter of the fiscal year 2026. For fiscal years 2025 and 2026, we expect to realize cost savings as a result of the May 2025 restructuring plan. See Note 12, "Restructuring Charges" of our accompanying Notes to Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements (unaudited)" of this Quarterly Report on Form 10-Q for additional details.

We have presented revenues for our two product lines, Subscription Services and Skills and Other, based on how students view us and the utilization of our products by them. More detail on our two product lines is discussed in the next two sections titled "Subscription Services" and "Skills and Other."

***Subscription Services***

***Skills and Other***

Our Skills and Other product line includes revenues from Chegg Skills, advertising services, content licensing, print textbooks and eTextbooks. Our Chegg Skills learning platform offers professional courses focused on the latest technology skills. We work with leading brands and programmatic partners to deliver advertising across our platforms. Beginning in the first quarter of 2025, we enter into non-exclusive content library licensing agreements with third parties. We also provide a platform for students to rent or buy print textbooks and eTextbooks, which helps students save money compared to the cost of buying new.

***Seasonality of Our Business***

Revenues from Subscription Services are primarily recognized ratably over the subscription term which has generally resulted in our highest revenues and profitability in the fourth quarter as it reflects more days of the academic year. Certain variable expenses, such as marketing expenses, remain highest in the first and third quarters such that our profitability may not provide meaningful insight on a sequential basis. As a result of these factors, the most concentrated periods for our revenues and expenses do not necessarily coincide, and comparisons of our historical quarterly results of operations on a sequential basis may not provide meaningful insight into our overall financial performance.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Results of Operations**

The following table presents our historical condensed consolidated statements of operations (in thousands, except percentage of total net revenues):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** |
| | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
| Net revenues | $105120 | 100% | $163147 | 100% | $226507 | 100% | $337497 | 100% |
| Cost of revenues<sup>(1)</sup> | 35478 | 34 | 45411 | 28 | 89451 | 39 | 91908 | 27 |
| Gross profit | 69642 | 66 | 117736 | 72 | 137056 | 61 | 245589 | 73 |
| Operating expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development<sup>(1)</sup> | 28717 | 27 | 43651 | 27 | 58145 | 26 | 88086 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing<sup>(1)</sup> | 17417 | 17 | 23545 | 14 | 43031 | 19 | 53920 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative<sup>(1)</sup> | 59966 | 57 | 54016 | 33 | 99340 | 44 | 109550 | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment expense |  | n/m | 481531 | n/m | 2000 | 1 | 481531 | n/m |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 106100 | 101 | 602743 | n/m | 202516 | 89 | 733087 | n/m |
| Loss from operations | (36458) | (35) | (485007) | n/m | (65460) | (29) | (487498) | n/m |
| Total interest expense, net and other income, net | 2018 | 2 | 6468 | 4 | 14548 | 6 | 16598 | 5 |
| Loss before provision for income taxes | (34440) | (33) | (478539) | n/m | (50912) | (22) | (470900) | n/m |
| Provision for income taxes | (1223) | (1) | (138345) | n/m | (2235) | (1) | (147404) | n/m |
| Net loss | $(35663) | (34)% | $(616884) | n/m | $(53147) | (23)% | $(618304) | n/m |
| <sup>(1)</sup> Includes share-based compensation expense and restructuring charges as follows: |  |  |  |  |  |  |  |  |
| Share-based compensation expense: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues | $131 |  | $466 |  | $369 |  | $979 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 1584 |  | 7123 |  | 4796 |  | 16332 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 413 |  | 1726 |  | 1474 |  | 3866 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 5784 |  | 8732 |  | 12530 |  | 26159 |  |
| Total share-based compensation expense | $7912 |  | $18047 |  | $19169 |  | $47336 |  |
| Restructuring charges: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues | $741 |  | $191 |  | $741 |  | $191 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 6833 |  | 2082 |  | 7792 |  | 2082 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 2010 |  | 906 |  | 2142 |  | 906 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 9338 |  | 3549 |  | 11167 |  | 3549 |  |
| Total restructuring charges | $18922 |  | $6728 |  | $21842 |  | $6728 |  |

---

*____________________________________*

\*n/m - not meaningful

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

***Three and Six Months Ended June 30, 2025 and 2024***

*&nbsp;&nbsp;&nbsp;&nbsp;*

*Net Revenues*&nbsp;&nbsp;&nbsp;&nbsp;

The following tables present our total net revenues for the periods shown for our Subscription Services and Skills and Other product lines (in thousands, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Subscription Services | $89727 | $146813 | (39)% |
| Skills and Other | 15393 | 16334 | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net revenues | $105120 | $163147 | (36) |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Subscription Services | $197293 | $300864 | (34)% |
| Skills and Other | 29214 | 36633 | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net revenues | $226507 | $337497 | (33) |

---

Subscription Services revenues decreased $57.1 million, or 39%, and $103.6 million, or 34%, during the three and six months ended June 30, 2025, respectively, compared to the same period in 2024. The decrease was primarily due to a 40% and 31% decrease in subscribers who have paid to access our services during the three months ended June 30, 2025 and March 31, 2025, respectively, compared to the same periods in 2024.

Skills and Other revenues decreased $0.9 million, or 6%, during the three months ended June 30, 2025, compared to the same period in 2024, primarily due to a decrease in Chegg Skills of $3.3 million related to lower enrollments and a decrease in advertising services revenue of $3.9 million due to lower fulfillment partially offset by content licensing revenue of $6.6 million. Skills and Other revenues decreased $7.4 million, or 20%, during the six months ended June 30, 2025, compared to the same period in 2024, primarily due to a decrease in Chegg Skills of $8.3 million related to lower enrollments and a decrease in advertising services revenues of $7.7 million due to lower fulfillment partially offset by content licensing revenue of $10.6 million.

*Cost of Revenues*

The following tables present our cost of revenues for the periods shown (in thousands, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Cost of revenues<sup>(1)</sup> | $35478 | $45411 | (22)% |
| <sup>(1)</sup>Includes share-based compensation expense of: | $131 | $466 | (72)% |
| <sup>(1)</sup>Includes restructuring charges of: | $741 | $191 | 288% |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Cost of revenues<sup>(1)</sup> | $89451 | $91908 | (3)% |
| <sup>(1)</sup>Includes share-based compensation expense of: | $369 | $979 | (62)% |
| <sup>(1)</sup>Includes restructuring charges of: | $741 | $191 | 288% |

---

Cost of revenues decreased $9.9 million, or 22%, during the three months ended June 30, 2025, compared to the same period in 2024. The decrease was primarily due to lower payment processing and other order fees of $4.8 million, primarily due to the decrease in subscribers who have paid to access our services, lower employee-related expenses of $1.2 million, and lower depreciation and amortization expense of $2.8 million. Gross margins decreased to 66% during the three months ended June 30, 2025, from 72% during the same period in 2024.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

Cost of revenues decreased $2.5 million, or 3%, during the six months ended June 30, 2025, compared to the same period in 2024. The decrease was primarily due to lower contractor spend of $1.5 million, lower employee-related expenses of $2.2 million, lower payment processing and other order fees of $8.5 million, which is primarily due to the decrease in subscribers who have paid to access our services, which was partially offset by higher depreciation and amortization expense of $10.5 million primarily due to the accelerated depreciation recorded as we streamlined our product experiences. Gross margins decreased to 61% during the six months ended June 30, 2025, from 73% during the same period in 2024.

*Operating Expenses*

The following tables present our total operating expenses for the periods shown (in thousands, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Research and development<sup>(1)</sup> | $28717 | $43651 | (34)% |
| Sales and marketing<sup>(1)</sup> | 17417 | 23545 | (26) |
| General and administrative<sup>(1)</sup> | 59966 | 54016 | 11 |
| Impairment expense |  | 481531 | n/m |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | $106100 | $602743 | (82) |
| <sup>(1)</sup> Includes share-based compensation expense and restructuring charges as follows: |  |  |  |
| Share-based compensation expense: |  |  |  |
| Research and development | $1584 | $7123 | (78)% |
| Sales and marketing | 413 | 1726 | (76) |
| General and administrative | 5784 | 8732 | (34) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | $7781 | $17581 | (56) |
| Restructuring charges: |  |  |  |
| Research and development | $6833 | $2082 | 228% |
| Sales and marketing | 2010 | 906 | 122 |
| General and administrative | 9338 | 3549 | 163 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | $18181 | $6537 | 178 |

---

*______________________________*

\*n/m - not meaningful

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Research and development<sup>(1)</sup> | $58145 | $88086 | (34)% |
| Sales and marketing<sup>(1)</sup> | 43031 | 53920 | (20) |
| General and administrative<sup>(1)</sup> | 99340 | 109550 | (9) |
| Impairment expense | 2000 | 481531 | n/m |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | $202516 | $733087 | (72) |
| <sup>(1)</sup> Includes share-based compensation expense and restructuring charges as follows: |  |  |  |
| Share-based compensation expense: |  |  |  |
| Research and development | $4796 | $16332 | (71)% |
| Sales and marketing | 1474 | 3866 | (62) |
| General and administrative | 12530 | 26159 | (52) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | $18800 | $46357 | (59) |
| Restructuring charges: |  |  |  |
| Research and development | $7792 | $2082 | 274% |
| Sales and marketing | 2142 | 906 | 136 |
| General and administrative | 11167 | 3549 | 215 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | $21101 | $6537 | 223 |

---

*______________________________*

\*n/m - not meaningful

Operating expenses decreased $496.6 million, or 82%, and $530.6 million, or 72%, during the three and six months ended June 30, 2025, respectively, compared to the same periods in 2024, primarily due to the absence of impairment expenses of $481.5 million recognized fiscal year 2024. The remaining decrease was primarily related to lower employee-related expenses and contractor spend as a result of restructuring actions. See "Note 1, "Background and Basis of Presentation" and Note 12, "Restructuring Charges" of our accompanying Notes to Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements (unaudited)" of this Quarterly Report on Form 10-Q for additional information regarding impairment expense and the restructuring actions, respectively.

*Research and Development*

Research and development expenses decreased $14.9 million, or 34%, during the three months ended June 30, 2025 compared to the same period in 2024. The decrease was primarily due to lower employee-related expenses of $16.7 million, including share-based compensation expense, and lower contractor spend of $1.6 million, partially offset by higher restructuring charges of $4.8 million. Research and development expenses as a percentage of net revenues were flat at 27% during the three months ended June 30, 2025 and 2024.

Research and development expenses decreased $29.9 million, or 34%, during the six months ended June 30, 2025 compared to the same period in 2024. The decrease was primarily due to lower employee-related expenses of $30.2 million, including share-based compensation expense, lower contractor spend of $3.6 million, and $1.2 million in lower technology expenses, partially offset by higher restructuring charges of $5.7 million. Research and development expenses as a percentage of net revenues were flat at 26% during the six months ended June 30, 2025 and 2024.

*Sales and Marketing*

Sales and marketing expenses decreased by $6.1 million, or 26%, during the three months ended June 30, 2025, compared to the same period in 2024. The decrease was primarily attributable to lower employee-related expenses of $3.6 million, including share-based compensation expense, lower paid marketing expenses of $1.1 million, lower indirect marketing expenses of $1.8 million, and lower amortization expense of $0.5 million, partially offset by higher restructuring charges of $1.1 million. Sales and marketing expenses as a percentage of net revenues were 17% during the three months ended June 30, 2025 compared to 14% during the same period in 2024.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

Sales and marketing expenses decreased by $10.9 million, or 20%, during the six months ended June 30, 2025, compared to the same period in 2024. The decrease was primarily attributable to lower employee-related expenses of $5.7 million, including share-based compensation expense, lower paid marketing expenses of $1.0 million, lower indirect marketing expenses of $2.9 million, and lower depreciation and amortization expense of $1.3 million, partially offset by higher restructuring charges of $1.2 million. Sales and marketing expenses as a percentage of net revenues were 19% during the six months ended June 30, 2025 compared to 16% during the same period in 2024.

*General and Administrative*

General and administrative expenses increased $6.0 million, or 11%, during the three months ended June 30, 2025 compared to the same period in 2024. The increase was due to higher restructuring charges of $5.8 million, a $6.0 million impairment loss on a strategic equity investment, and a $7.5 million loss contingency accrual, partially offset by lower employee-related expenses of $8.8 million, lower professional fees of $3.8 million, and lower contractor spend of $1.2 million. General and administrative expenses as a percentage of net revenues were 57% during the three months ended June 30, 2025 compared to 33% during the same period in 2024.

General and administrative expenses decreased $10.2 million, or 9%, during the six months ended June 30, 2025 compared to the same period in 2024. The decrease was due to lower employee-related expenses of $22.8 million, which is primarily due to share-based compensation expense, lower professional fees of $6.8 million, and lower contractor spend of $1.9 million, partially offset by higher restructuring charges of $7.6 million, a $6.0 million impairment loss on a strategic equity investment, and a $7.5 million loss contingency accrual. General and administrative expenses as a percentage of net revenues were 44% during the three months ended June 30, 2025 compared to 32% during the same period in 2024.

*Impairment Expense*

Impairment expense was $2.0 million during the six months ended June 30, 2025, consisting of impairment of property and equipment. See Note 5, Property and Equipment, Net" of our accompanying Notes to Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements (unaudited)" of this Quarterly Report on Form 10-Q for additional information. Impairment expense was $481.5 million during the three and six months ended June 30, 2024, consisting of impairments of goodwill, intangible assets, and other related long-lived assets. See "Note 1, Background and Basis of Presentation" and "Note 5, Property and Equipment" of our accompanying Notes to Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements (unaudited)" of this Quarterly Report on Form 10-Q for additional information.

*Interest Expense, net and Other Income, Net*

The following tables present our interest expense, net and other income, net, for the periods shown (in thousands, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Interest expense, net | $(41) | $(651) | (94)% |
| Other income, net | 2059 | 7119 | (71) |
| Interest expense, net and other income, net: | $2018 | $6468 | (69) |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Interest expense, net | $(508) | $(1301) | (61)% |
| Other income, net | 15056 | 17899 | (16) |
| Interest expense, net and other income, net: | $14548 | $16598 | (12) |

---

Interest expense, net decreased $0.6 million, or 94%, and $0.8 million, or 61%, during the three and six months ended June 30, 2025, respectively, compared to the same periods in 2024, primarily due to the maturity of the 2025 notes and the early extinguishment of a portion of the 2026 notes.

Other income, net decreased $5.1 million, or 71%, during the three months ended June 30, 2025 compared to the same period in 2024, primarily due to a decrease in interest income of $5.7 million due to lower investment balances.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

Other income, net decreased $2.8 million, or 16%, during the six months ended June 30, 2025 compared to the same period in 2024, primarily due to a decrease in interest income of $7.8 million due to lower investment balances and the absence of the gain on sale of the strategic equity investment in Sound Ventures of $3.8 million, partially offset by the $7.4 million gain on early extinguishment of a portion of the 2026 notes.

*Provision for income taxes*

The following tables present our provision for income taxes for the periods shown (in thousands, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended <br>June 30,** | **Three Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Provision for income taxes | (1223) | (138345) | n/m |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Provision for income taxes | (2235) | (147404) | n/m |

---

*______________________________*

\*n/m - not meaningful

Provision for income taxes decreased $137.1 million and $145.2 million during the three and six months ended June 30, 2025, compared to the same periods in 2024, primarily due to the valuation allowance established in fiscal year 2024 against our U.S. federal and state deferred tax assets.

**Liquidity and Capital Resources**

The following table presents our cash, cash equivalents and investments and convertible senior notes as of the periods shown (in thousands, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | | | **Change** |
| | **June 30, 2025** | **December 31, 2024** | $**%** |
| Cash, cash equivalents and investments | $114114 | $528374 | (78)% |
| Convertible senior notes, net<sup>(1)</sup> | 62516 | 485949 | (87) |

---

*______________________________________*

<sup>(1)</sup> Consists of the current and long-term portion of convertible senior notes, net.

Cash, cash equivalents, and investments decreased $414.3 million, or 78%, and convertible senior notes, net decreased $423.4 million, or 87% during the six months ended June 30, 2025. The decreases were primarily due to the net cash used for the maturity of the 2025 notes and the early extinguishment of a portion of the 2026 notes.

As of June 30, 2025, our principal sources of liquidity were cash, cash equivalents, and investments totaling $114.1 million, which were held for working capital purposes. We believe that our existing sources of liquidity as well as net cash flows from operations will be sufficient to fund our operations and debt service obligations for at least the next 12 months. Our future capital requirements will depend on many factors, including our rate of revenue growth, our investments in research and development activities, our acquisition of new products and services and our sales and marketing activities. To the extent that existing sources of liquidity are insufficient to fund our future operations, we may need to raise additional funds through public or private equity or debt financing. Additional funds may not be available on terms favorable to us or at all. If adequate funds are not available on acceptable terms, or at all, we may be unable to adequately fund our business plans and it could have a negative effect on our business, operating cash flows and financial condition. As of June 30, 2025, we have incurred cumulative losses of $942.6 million from our operations and we may incur additional losses in the future.

Most of our cash, cash equivalents, and investments are held in the United States. As part of our ongoing cash management, we intend to repatriate a portion of earnings from our subsidiary in India by the end of fiscal year 2025. Accordingly, we do not assert an indefinite reinvestment of earnings and accrued a withholding tax of $2.0 million as of June 30, 2025, related to a potential future distribution of such earnings. This reflects our continued assessment of cash needs and the absence of an indefinite reinvestment assertion for our subsidiary in India. As a result of the Tax Cuts and Jobs Act, we anticipate the U.S. federal impact for the remaining foreign jurisdictions to be minimal if these funds are repatriated. In

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

addition, based on our current and future needs, we believe our current funding and capital resources for our international operations are adequate.

There were no material changes in our commitments under contractual obligations, as disclosed in Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" contained in our Annual Report on Form 10-K for the year ended December 31, 2024.

The following table presents our condensed consolidated statements of cash flows data (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended <br>June 30,** | **Six Months Ended <br>June 30,** | **Change** |
| | **2025** | **2024** | $**%** |
| Net cash flows from operating activities | $19686 | $67545 | (71)% |
| Net cash flows from investing activities | 272180 | (64096) | n/m |
| Net cash flows from financing activities | (417138) | (5635) | n/m |

---

*_______________________________________*

\*n/m - not meaningful&nbsp;&nbsp;&nbsp;&nbsp;

The substantial majority of our cash inflows from operating activities are from e-commerce transactions with students, which are settled immediately through payment processors, as opposed to cash outflows from bill payments, which are settled based on contractual payment terms with our suppliers.

Net cash flows from operating activities decreased $47.9 million, or 71%, during the six months ended June 30, 2025 compared to the same period in 2024 and was primarily related to a decrease in impairment expense of $480.0 million, as well as a decrease in deferred tax assets of $140.9 million, partially offset by a decrease in net loss of $565.2 million.

Net cash flows from investing activities increased $336.3 million during the six months ended June 30, 2025 compared to the same period in 2024 and was primarily related to higher proceeds from the sale of investments of $181.2 million, fewer purchases of investments of $122.9 million, higher proceeds from the maturities of our investments of $17.8 million, fewer purchases of property and equipment of $29.9 million partially offset by the absence of proceeds from the sale of our strategic investment of $15.5 million that occurred in the six months ended June 30, 2024.

Net cash flows from financing activities decreased $411.5 million during the six months ended June 30, 2025 compared to the same period in 2024 and was primarily related to the repayment of our convertible debt of $416.5 million.

**Critical Accounting Policies, Significant Judgments and Estimates**

Our condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP). The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures. These estimates form the basis for judgments we make about the carrying values of our assets and liabilities, which are not readily apparent from other sources. We base our estimates and judgments on historical experience and on various other assumptions that we believe are reasonable under the circumstances. On an ongoing basis, we evaluate our estimates and assumptions. Our actual results may differ from these estimates under different assumptions or conditions.

There have been no material changes in our critical accounting policies and estimates during the six months ended June 30, 2025 as compared to the critical accounting policies and estimates disclosed in Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" contained in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Recent Accounting Pronouncements**

For relevant recent accounting pronouncements, see Note 1, "Background and Basis of Presentation," of our accompanying Notes to Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements (unaudited)" of this Quarterly Report on Form 10-Q.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

There have been no material changes in our market risk during the six months ended June 30, 2025, compared to the disclosures in Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk" contained in our Annual Report on Form 10-K for the year ended December 31, 2024.

**ITEM 4. CONTROLS AND PROCEDURES**

**(a)Evaluation of Disclosure Controls and Procedures**

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this report.

In designing and evaluating our disclosure controls and procedures, management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Based on management's evaluation, our principal executive officer and principal financial officer concluded that, as of June 30, 2025, our disclosure controls and procedures are designed to, and are effective to, provide assurance at a reasonable level that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

**(b)Changes in Internal Control over Financial Reporting**

During the three months ended June 30, 2025, there were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**PART II - OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

We may from time to time be subject to certain legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, patents, copyrights, and other intellectual property rights; employment claims; and general contract or other claims. We may also, from time to time, be subject to various legal or government claims, demands, disputes, investigations, or requests for information. Such matters may include, but not be limited to, claims, disputes, or investigations related to warranty, refund, breach of contract, employment, intellectual property, government regulation, or compliance or other matters. See Note 8, "Commitments and Contingencies," of our accompanying Notes to Condensed Consolidated Financial Statements included in Part I, Item 1, "Financial Statements (unaudited)" of this Quarterly Report on Form 10-Q for more information on our legal proceedings.

In addition, on February 24, 2025, we filed a complaint in the U.S. District Court for the District of Columbia against Google LLC and Alphabet Inc. ("Google"), asserting federal antitrust claims and common-law unjust enrichment claims, in connection with Google's expansion of its AIO search experience, and seeking damages, restitution, disgorgement, and injunctive relief. Google moved to dismiss the amended complaint on July 25, 2025. Given the nature of the case, including that the proceedings are in their early stages, we are unable to predict the ultimate outcome of the case.

**ITEM 1A. RISK FACTORS**

Our operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common stock. There have been no material changes in our risk factors from our Annual Report on Form 10-K, except as described below:

***We have in the past, and may in the future, be unable to comply with the listing standards of the New York Stock Exchange, or NYSE. Our failure to maintain compliance with the continued listing requirements of the NYSE could result in the delisting of our common stock, which would have an adverse impact on the trading, liquidity and market price of our common stock.***

Our common stock is currently listed on NYSE, which has minimum standards that a company must meet in order to remain listed. These standards provide that a company will be considered to be below compliance standards if the average closing price of its common stock is less than $1.00 over a consecutive 30 trading-day period. On April 1, 2025, we were notified by NYSE that we were not in compliance with NYSE's minimum share price requirement. On July 1, 2025, following a period of stock price appreciation we received a price cure letter from NYSE confirming we had regained compliance with the minimum share price requirement. However, closing prices of our common stock on NYSE have remained close to $1.00 more recently and, accordingly, there can be no assurance that we will remain in compliance with NYSE's minimum share price requirement or any of the NYSE's other applicable continued listing standards. Any future failure to remain in compliance with the NYSE's continued listing standards, and any subsequent failure to timely resume compliance with the NYSE's continued listing standards within the applicable cure period, if any, could result in a suspension or delisting, and have adverse consequences, including, among others, reducing the number of investors willing to hold or acquire our common stock, loss of confidence from stakeholders, employees and potential business partners, reducing the liquidity and market price of our common stock, adverse publicity, and a reduced interest in us from investors, analysts and other market participants. In addition, a suspension or delisting could impair our ability to raise additional capital through the public markets, result in negative publicity, adversely affect the market liquidity of our securities, decrease securities analysts' coverage of us, diminish investor, supplier and employee confidence and impair our ability to attract and retain employees by means of equity compensation.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

**Unregistered Sales of Securities**

We had no unregistered sales of our securities during the three months ended June 30, 2025.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**Purchases of Securities by the Registrant and Affiliated Purchasers**

We did not purchase any of our common stock during the three months ended June 30, 2025.

**ITEM 5. OTHER INFORMATION**

**Rule 10b5-1 Trading Plans**

During the three months ended June 30, 2025, none of our Section 16 officers or directors adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as defined in Item 408 of Regulation S-K during the covered period.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**ITEM 6. EXHIBITS**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** |
| **Exhibit<br>No.** | **Exhibit** | **Form** | **File No** | **Filing Date** | **Exhibit No.** | **Filed<br>Herewith** |
| <u>[3.01](https://www.sec.gov/Archives/edgar/data/1364954/000136495416000291/ex3012015-12x31.htm)</u> | <u>[Restated Certificate of Incorporation of Chegg, Inc. effective November 18, 2013](https://www.sec.gov/Archives/edgar/data/1364954/000136495416000291/ex3012015-12x31.htm)</u> | 10-K | 001-36180 | 3/4/2016 | 3.01 |  |
| <u>[3.02](https://www.sec.gov/Archives/edgar/data/1364954/000136495423000042/ex31-0315238xk.htm)</u> | <u>[Amended and Restated Bylaws of Chegg, Inc., as amended on March 15, 2023](https://www.sec.gov/Archives/edgar/data/1364954/000136495423000042/ex31-0315238xk.htm)</u> | 8-K | 001-36180 | 3/21/2023 | 3.1 |  |
| <u>[10.1](https://www.sec.gov/Archives/edgar/data/1364954/000136495425000060/a0604258-kex101.htm)[\*](https://www.sec.gov/Archives/edgar/data/1364954/000136495425000060/a0604258-kex101.htm)</u> | <u>[Amendment No. 1 to the Chegg, Inc. 2023 Equity Incentive Plan](https://www.sec.gov/Archives/edgar/data/1364954/000136495425000060/a0604258-kex101.htm)</u> | 8-K | 001-36180 | 6/6/2025 | 10.1 |  |
| <u>[31.01](ex31012025-06x30.htm)</u> | <u>[Certification of Nathan Schultz, Chief Executive Officer and President, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31012025-06x30.htm)</u> |  |  |  |  | X |
| <u>[31.02](ex31022025-06x30.htm)</u> | <u>[Certification of David Longo, Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31022025-06x30.htm)</u> |  |  |  |  | X |
| <u>[32.01\*\*](ex32012025-06x30.htm)</u> | <u>[Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32012025-06x30.htm)</u> |  |  |  |  | X |
| 101.INS | Inline XBRL Instance Document |  |  |  |  | X |
| 101.SCH | Inline XBRL Taxonomy Extension Schema |  |  |  |  | X |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation |  |  |  |  | X |
| 101.LAB | Inline XBRL Taxonomy Extension Labels |  |  |  |  | X |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation |  |  |  |  | X |
| 101.DEF | Inline XBRL Taxonomy Extension Definition |  |  |  |  | X |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |  |  |  |  | X |

---

\* Indicates a management contract or compensatory plan.

\*\* This certification is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

------

<u>[**Table of Contents**](#i97e364368d554c98b9ba52792f723c3b_7)</u> 

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | CHEGG, INC. | CHEGG, INC. |
| August 8, 2025 | By: | /S/ DAVID LONGO |
|  |  | David Longo |
|  |  | Chief Financial Officer |
|  |  | (Principal Financial Officer and Principal Accounting Officer) |

---

## Exhibit 31.01

**Exhibit 31.01** 

**CERTIFICATION PURSUANT TO** 

**RULE 13a-14(a)/15d-14(a)** 

**AS ADOPTED PURSUANT TO** 

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002** 

I, Nathan Schultz, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Chegg, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 8, 2025

---

| |
|:---|
| /S/ NATHAN SCHULTZ |
| Nathan Schultz |
| *Chief Executive Officer and President* |
| (Principal Executive Officer) |

---

## Exhibit 31.02

**Exhibit 31.02** 

**CERTIFICATION PURSUANT TO** 

**RULE 13a-14(a)/15d-14(a)** 

**AS ADOPTED PURSUANT TO** 

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002** 

I, David Longo, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Chegg, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 8, 2025

---

| |
|:---|
| /S/ DAVID LONGO |
| David Longo |
| *Chief Financial Officer* |
| (Principal Financial Officer and Principal Accounting Officer) |

---

## Exhibit 32.01

**Exhibit 32.01** 

**CERTIFICATION** 

**PURSUANT TO** 

**18 U.S.C. SECTION 1350** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report on Form 10-Q for the three months ended June 30, 2025 of Chegg, Inc. (the "Registrant") filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, each certify, in accordance with Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that to the best of his knowledge:

(1)The Report, to which this certification is attached as Exhibit 32.01, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Dated: August 8, 2025

---

| | |
|:---|:---|
| /S/ NATHAN SCHULTZ | /S/ DAVID LONGO |
| Nathan Schultz | David Longo |
| Chief Executive Officer and President | Chief Financial Officer |

---

<br>